Cargando…
Aberrant Alternative Splicing Is Another Hallmark of Cancer
The vast majority of human genes are alternatively spliced. Not surprisingly, aberrant alternative splicing is increasingly linked to cancer. Splice isoforms often encode proteins that have distinct and even antagonistic properties. The abnormal expression of splice factors and splice factor kinases...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786539/ https://www.ncbi.nlm.nih.gov/pubmed/24101931 http://dx.doi.org/10.1155/2013/463786 |
_version_ | 1782477756689285120 |
---|---|
author | Ladomery, Michael |
author_facet | Ladomery, Michael |
author_sort | Ladomery, Michael |
collection | PubMed |
description | The vast majority of human genes are alternatively spliced. Not surprisingly, aberrant alternative splicing is increasingly linked to cancer. Splice isoforms often encode proteins that have distinct and even antagonistic properties. The abnormal expression of splice factors and splice factor kinases in cancer changes the alternative splicing of critically important pre-mRNAs. Aberrant alternative splicing should be added to the growing list of cancer hallmarks. |
format | Online Article Text |
id | pubmed-3786539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-37865392013-10-07 Aberrant Alternative Splicing Is Another Hallmark of Cancer Ladomery, Michael Int J Cell Biol Review Article The vast majority of human genes are alternatively spliced. Not surprisingly, aberrant alternative splicing is increasingly linked to cancer. Splice isoforms often encode proteins that have distinct and even antagonistic properties. The abnormal expression of splice factors and splice factor kinases in cancer changes the alternative splicing of critically important pre-mRNAs. Aberrant alternative splicing should be added to the growing list of cancer hallmarks. Hindawi Publishing Corporation 2013 2013-09-11 /pmc/articles/PMC3786539/ /pubmed/24101931 http://dx.doi.org/10.1155/2013/463786 Text en Copyright © 2013 Michael Ladomery. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Ladomery, Michael Aberrant Alternative Splicing Is Another Hallmark of Cancer |
title | Aberrant Alternative Splicing Is Another Hallmark of Cancer |
title_full | Aberrant Alternative Splicing Is Another Hallmark of Cancer |
title_fullStr | Aberrant Alternative Splicing Is Another Hallmark of Cancer |
title_full_unstemmed | Aberrant Alternative Splicing Is Another Hallmark of Cancer |
title_short | Aberrant Alternative Splicing Is Another Hallmark of Cancer |
title_sort | aberrant alternative splicing is another hallmark of cancer |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786539/ https://www.ncbi.nlm.nih.gov/pubmed/24101931 http://dx.doi.org/10.1155/2013/463786 |
work_keys_str_mv | AT ladomerymichael aberrantalternativesplicingisanotherhallmarkofcancer |